Suchergebnisse - (Person:"Fajgenbaum, David C")

PubPharm (6)

1

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

enthalten in: The Journal of clinical investigation | 2019

von Fajgenbaum, D. | Langan, R. | Japp, A. | +20

CommentIn: J Clin Invest. 2019 Oct 1;129(10):4086-4088. - PMID 31524635

2

Letter to the editor regarding 'Non-cirrhotic portal hypertension associated with multicentric Castleman's disease : a case report'

enthalten in: Acta oncologica (Stockholm, Sweden) | 2019

von Kobrin, D. | Pinto, A. | Parente, S. | +4

3

A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease

enthalten in: Blood advances | 2018

von Baker, T. | Gambino, K. | Schriefer, L. | +5

4

Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome

enthalten in: Annals of hematology | 2017

von Behnia, F. | Elojeimy, S. | Matesan, M. | +1

5

TAFRO Syndrome in Caucasians : A Case Report and Review of the Literature

enthalten in: Frontiers in medicine | 2017

von Louis, C. | Vijgen, S. | Samii, K. | +6

6

Eruptive cherry hemangiomatosis associated with multicentric Castleman disease : a case report and diagnostic clue

enthalten in: JAMA dermatology | 2013

von Fajgenbaum, D. | Fajgenbaum, D. | Rosenbach, M. | +3

ErratumIn: JAMA Dermatol. 2014 Apr;150(4):460 Fajgenbaum, David [corrected to Fajgenbaum, David C]

1
[1]